David J Becker

Summary

Publications

  1. ncbi Simvastatin vs therapeutic lifestyle changes and supplements: randomized primary prevention trial
    David J Becker
    Division of Cardiology, Chestnut Hill Hospital, University of Pennsylvania Health System, Philadelphia, PA, USA
    Mayo Clin Proc 83:758-64. 2008
  2. ncbi Red yeast rice for dyslipidemia in statin-intolerant patients: a randomized trial
    David J Becker
    Chestnut Hill Hospital, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, USA
    Ann Intern Med 150:830-9, W147-9. 2009
  3. ncbi Tolerability of red yeast rice (2,400 mg twice daily) versus pravastatin (20 mg twice daily) in patients with previous statin intolerance
    Steven C Halbert
    Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, USA
    Am J Cardiol 105:198-204. 2010
  4. ncbi The role of red yeast rice for the physician
    Ram Y Gordon
    Division of Cardiology, Chestnut Hill Hospital, Philadelphia, PA 19118, USA
    Curr Atheroscler Rep 13:73-80. 2011
  5. ncbi Marked variability of monacolin levels in commercial red yeast rice products: buyer beware!
    Ram Y Gordon
    Chestnut Hill Hospital, University of Pennsylvania Health System, Philadelphia, USA
    Arch Intern Med 170:1722-7. 2010

Collaborators

Detail Information

Publications5

  1. ncbi Simvastatin vs therapeutic lifestyle changes and supplements: randomized primary prevention trial
    David J Becker
    Division of Cardiology, Chestnut Hill Hospital, University of Pennsylvania Health System, Philadelphia, PA, USA
    Mayo Clin Proc 83:758-64. 2008
    ..To compare the lipid-lowering effects of an alternative regimen (lifestyle changes, red yeast rice, and fish oil) with a standard dose of a 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor (statin)...
  2. ncbi Red yeast rice for dyslipidemia in statin-intolerant patients: a randomized trial
    David J Becker
    Chestnut Hill Hospital, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, USA
    Ann Intern Med 150:830-9, W147-9. 2009
    ..Red yeast rice is an herbal supplement that decreases low-density lipoprotein (LDL) cholesterol level...
  3. ncbi Tolerability of red yeast rice (2,400 mg twice daily) versus pravastatin (20 mg twice daily) in patients with previous statin intolerance
    Steven C Halbert
    Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, USA
    Am J Cardiol 105:198-204. 2010
    ..In conclusion, red yeast rice was tolerated as well as pravastatin and achieved a comparable reduction of low-density lipoprotein cholesterol in a population previously intolerant to statins...
  4. ncbi The role of red yeast rice for the physician
    Ram Y Gordon
    Division of Cardiology, Chestnut Hill Hospital, Philadelphia, PA 19118, USA
    Curr Atheroscler Rep 13:73-80. 2011
    ..Therefore, until red yeast rice products are regulated and standardized, physicians and patients should be cautious in recommending this promising alternative therapy for hyperlipidemia...
  5. ncbi Marked variability of monacolin levels in commercial red yeast rice products: buyer beware!
    Ram Y Gordon
    Chestnut Hill Hospital, University of Pennsylvania Health System, Philadelphia, USA
    Arch Intern Med 170:1722-7. 2010
    ..We evaluated monacolin levels in 12 commercial RYR formulations and tested for citrinin, a mycotoxin that is nephrotoxic in animals...